nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G1B—atherosclerosis	0.454	0.887	CbGaD
Niflumic Acid—SLC16A1—Niacin—atherosclerosis	0.21	0.564	CbGbCtD
Niflumic Acid—SLC16A1—Pravastatin—atherosclerosis	0.162	0.436	CbGbCtD
Niflumic Acid—PTGS2—atherosclerosis	0.0582	0.114	CbGaD
Niflumic Acid—PLA2G1B—blood vessel—atherosclerosis	0.0029	0.111	CbGeAlD
Niflumic Acid—Leflunomide—AHR—atherosclerosis	0.00266	0.82	CrCbGaD
Niflumic Acid—CLCNKA—liver—atherosclerosis	0.00203	0.0777	CbGeAlD
Niflumic Acid—PTGS2—leg—atherosclerosis	0.00156	0.06	CbGeAlD
Niflumic Acid—PLA2G1B—connective tissue—atherosclerosis	0.00149	0.057	CbGeAlD
Niflumic Acid—PTGS2—hindlimb—atherosclerosis	0.0014	0.0536	CbGeAlD
Niflumic Acid—PLA2G1B—cardiovascular system—atherosclerosis	0.00129	0.0496	CbGeAlD
Niflumic Acid—PTGS2—appendage—atherosclerosis	0.0012	0.0459	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—atherosclerosis	0.00109	0.0418	CbGeAlD
Niflumic Acid—SLC16A7—adipose tissue—atherosclerosis	0.000961	0.0369	CbGeAlD
Niflumic Acid—PLA2G4A—connective tissue—atherosclerosis	0.000906	0.0347	CbGeAlD
Niflumic Acid—PTGS1—artery—atherosclerosis	0.000896	0.0344	CbGeAlD
Niflumic Acid—PTGS2—artery—atherosclerosis	0.000856	0.0328	CbGeAlD
Niflumic Acid—PLA2G4A—cardiovascular system—atherosclerosis	0.000788	0.0302	CbGeAlD
Niflumic Acid—PTGS1—endothelium—atherosclerosis	0.000757	0.029	CbGeAlD
Niflumic Acid—UGT1A9—liver—atherosclerosis	0.000732	0.0281	CbGeAlD
Niflumic Acid—PTGS2—endothelium—atherosclerosis	0.000723	0.0277	CbGeAlD
Niflumic Acid—PTGS1—blood vessel—atherosclerosis	0.000698	0.0268	CbGeAlD
Niflumic Acid—PLA2G4A—adipose tissue—atherosclerosis	0.000695	0.0267	CbGeAlD
Niflumic Acid—SLC16A1—cardiovascular system—atherosclerosis	0.000694	0.0266	CbGeAlD
Niflumic Acid—SLC16A7—liver—atherosclerosis	0.000674	0.0259	CbGeAlD
Niflumic Acid—PTGS2—blood vessel—atherosclerosis	0.000667	0.0256	CbGeAlD
Niflumic Acid—SLC16A1—adipose tissue—atherosclerosis	0.000612	0.0235	CbGeAlD
Niflumic Acid—SLC16A1—liver—atherosclerosis	0.000429	0.0165	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—atherosclerosis	0.000421	0.13	CrCbGaD
Niflumic Acid—PTGS1—connective tissue—atherosclerosis	0.000358	0.0137	CbGeAlD
Niflumic Acid—PTGS2—connective tissue—atherosclerosis	0.000342	0.0131	CbGeAlD
Niflumic Acid—PTGS1—cardiovascular system—atherosclerosis	0.000311	0.0119	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—atherosclerosis	0.000298	0.0114	CbGeAlD
Niflumic Acid—PTGS1—adipose tissue—atherosclerosis	0.000275	0.0105	CbGeAlD
Niflumic Acid—PTGS2—adipose tissue—atherosclerosis	0.000262	0.0101	CbGeAlD
Niflumic Acid—PTGS2—liver—atherosclerosis	0.000184	0.00706	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—atherosclerosis	0.000164	0.0506	CrCbGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LDLR—atherosclerosis	1.35e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—BGN—atherosclerosis	1.34e-05	0.000155	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOC3—atherosclerosis	1.34e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA4—atherosclerosis	1.34e-05	0.000155	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOB—atherosclerosis	1.34e-05	0.000155	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—LDLR—atherosclerosis	1.33e-05	0.000154	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.33e-05	0.000154	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOA5—atherosclerosis	1.33e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	1.32e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP7A1—atherosclerosis	1.32e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL3—atherosclerosis	1.32e-05	0.000152	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—atherosclerosis	1.31e-05	0.000151	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CETP—atherosclerosis	1.3e-05	0.000151	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—atherosclerosis	1.3e-05	0.000151	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.3e-05	0.00015	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.29e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.28e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLA2G1B—atherosclerosis	1.28e-05	0.000148	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—LPL—atherosclerosis	1.28e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—BGN—atherosclerosis	1.27e-05	0.000147	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.27e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCF1—atherosclerosis	1.26e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—atherosclerosis	1.26e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.25e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.25e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.25e-05	0.000144	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SCARB1—atherosclerosis	1.25e-05	0.000144	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—atherosclerosis	1.25e-05	0.000144	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALOX5—atherosclerosis	1.24e-05	0.000143	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.23e-05	0.000142	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP27A1—atherosclerosis	1.22e-05	0.000141	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CD36—atherosclerosis	1.22e-05	0.00014	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.22e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AGT—atherosclerosis	1.21e-05	0.000139	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.2e-05	0.000138	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.19e-05	0.000138	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDNRA—atherosclerosis	1.19e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR2—atherosclerosis	1.19e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CYBA—atherosclerosis	1.18e-05	0.000137	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMGCR—atherosclerosis	1.18e-05	0.000136	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.17e-05	0.000135	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PARP1—atherosclerosis	1.16e-05	0.000134	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GHRL—atherosclerosis	1.16e-05	0.000134	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PLAT—atherosclerosis	1.16e-05	0.000134	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G2A—atherosclerosis	1.15e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA2—atherosclerosis	1.15e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX5AP—atherosclerosis	1.15e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX15—atherosclerosis	1.15e-05	0.000133	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—atherosclerosis	1.15e-05	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.14e-05	0.000132	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCG5—atherosclerosis	1.14e-05	0.000132	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.14e-05	0.000131	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARA—atherosclerosis	1.13e-05	0.000131	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—F2—atherosclerosis	1.11e-05	0.000129	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.11e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—atherosclerosis	1.11e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CST3—atherosclerosis	1.11e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NAMPT—atherosclerosis	1.11e-05	0.000128	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.1e-05	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LPA—atherosclerosis	1.1e-05	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000126	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AGT—atherosclerosis	1.09e-05	0.000126	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—HMOX1—atherosclerosis	1.09e-05	0.000126	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LDLR—atherosclerosis	1.09e-05	0.000126	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—atherosclerosis	1.07e-05	0.000124	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—BGN—atherosclerosis	1.07e-05	0.000123	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CG—atherosclerosis	1.07e-05	0.000123	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.06e-05	0.000123	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CETP—atherosclerosis	1.06e-05	0.000123	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CAV1—atherosclerosis	1.06e-05	0.000123	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOA1—atherosclerosis	1.06e-05	0.000122	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.06e-05	0.000122	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA5—atherosclerosis	1.06e-05	0.000122	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ABCA1—atherosclerosis	1.05e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NAMPT—atherosclerosis	1.05e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MAPK3—atherosclerosis	1.05e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOB—atherosclerosis	1.04e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOC3—atherosclerosis	1.04e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LDLR—atherosclerosis	1.03e-05	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.03e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—atherosclerosis	1.02e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SCARB1—atherosclerosis	1.02e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KNG1—atherosclerosis	1.02e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.02e-05	0.000117	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000117	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGTR1—atherosclerosis	1.01e-05	0.000117	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1e-05	0.000116	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HSPA1B—atherosclerosis	9.96e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—LPL—atherosclerosis	9.95e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.95e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.93e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—atherosclerosis	9.92e-06	0.000115	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.91e-06	0.000114	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PLG—atherosclerosis	9.86e-06	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALOX5—atherosclerosis	9.81e-06	0.000113	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—atherosclerosis	9.71e-06	0.000112	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CG—atherosclerosis	9.68e-06	0.000112	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NCF1—atherosclerosis	9.65e-06	0.000111	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMGCR—atherosclerosis	9.61e-06	0.000111	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CD36—atherosclerosis	9.46e-06	0.000109	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—atherosclerosis	9.34e-06	0.000108	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SOCS3—atherosclerosis	9.34e-06	0.000108	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—INS—atherosclerosis	9.16e-06	0.000106	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—atherosclerosis	9.11e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CYBA—atherosclerosis	9.07e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.06e-06	0.000105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP3—atherosclerosis	9.02e-06	0.000104	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMOX1—atherosclerosis	9.02e-06	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF2—atherosclerosis	8.98e-06	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—atherosclerosis	8.96e-06	0.000103	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PARP1—atherosclerosis	8.88e-06	0.000103	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAMPT—atherosclerosis	8.8e-06	0.000102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARA—atherosclerosis	8.79e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.75e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LIPC—atherosclerosis	8.74e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOB—atherosclerosis	8.71e-06	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOC3—atherosclerosis	8.69e-06	0.0001	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.67e-06	0.0001	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LDLR—atherosclerosis	8.64e-06	9.97e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOB—atherosclerosis	8.64e-06	9.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	8.58e-06	9.9e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ABCA1—atherosclerosis	8.57e-06	9.89e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AGT—atherosclerosis	8.51e-06	9.83e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	8.51e-06	9.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CETP—atherosclerosis	8.44e-06	9.74e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—atherosclerosis	8.4e-06	9.7e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—atherosclerosis	8.4e-06	9.7e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—atherosclerosis	8.34e-06	9.63e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	8.32e-06	9.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.28e-06	9.56e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAV1—atherosclerosis	8.26e-06	9.54e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—LPL—atherosclerosis	8.25e-06	9.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOA1—atherosclerosis	8.25e-06	9.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	8.09e-06	9.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SCARB1—atherosclerosis	8.08e-06	9.33e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—atherosclerosis	8.04e-06	9.29e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—atherosclerosis	8.04e-06	9.28e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	7.88e-06	9.1e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.87e-06	9.08e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	7.85e-06	9.06e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CD36—atherosclerosis	7.83e-06	9.05e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMGCR—atherosclerosis	7.63e-06	8.81e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	7.53e-06	8.69e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—atherosclerosis	7.42e-06	8.57e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—atherosclerosis	7.35e-06	8.49e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—atherosclerosis	7.35e-06	8.49e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	7.29e-06	8.42e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARA—atherosclerosis	7.28e-06	8.41e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—atherosclerosis	7.27e-06	8.39e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—INS—atherosclerosis	7.13e-06	8.23e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	7.12e-06	8.22e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—atherosclerosis	7.09e-06	8.18e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AGT—atherosclerosis	7.05e-06	8.15e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOB—atherosclerosis	7.04e-06	8.13e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	6.97e-06	8.05e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	6.97e-06	8.05e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—atherosclerosis	6.91e-06	7.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	6.91e-06	7.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	6.89e-06	7.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—atherosclerosis	6.85e-06	7.91e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAV1—atherosclerosis	6.85e-06	7.91e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOA1—atherosclerosis	6.83e-06	7.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCA1—atherosclerosis	6.8e-06	7.85e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LPL—atherosclerosis	6.72e-06	7.76e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOB—atherosclerosis	6.67e-06	7.71e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	6.66e-06	7.69e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—F2—atherosclerosis	6.58e-06	7.59e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—atherosclerosis	6.56e-06	7.57e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—atherosclerosis	6.53e-06	7.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CD36—atherosclerosis	6.39e-06	7.37e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LPL—atherosclerosis	6.37e-06	7.36e-05	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—atherosclerosis	6.31e-06	7.29e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	6.29e-06	7.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—atherosclerosis	6.25e-06	7.22e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CG—atherosclerosis	6.24e-06	7.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRKCG—atherosclerosis	6.2e-06	7.15e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—atherosclerosis	6.05e-06	6.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	6.03e-06	6.96e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—atherosclerosis	6.02e-06	6.95e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INS—atherosclerosis	5.96e-06	6.88e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARA—atherosclerosis	5.94e-06	6.86e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—INS—atherosclerosis	5.9e-06	6.82e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	5.86e-06	6.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—atherosclerosis	5.83e-06	6.74e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	5.76e-06	6.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AGT—atherosclerosis	5.75e-06	6.64e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—atherosclerosis	5.74e-06	6.62e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—atherosclerosis	5.72e-06	6.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—atherosclerosis	5.63e-06	6.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOB—atherosclerosis	5.59e-06	6.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PDGFB—atherosclerosis	5.58e-06	6.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAV1—atherosclerosis	5.58e-06	6.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOA1—atherosclerosis	5.57e-06	6.43e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	5.47e-06	6.32e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—atherosclerosis	5.44e-06	6.28e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—atherosclerosis	5.41e-06	6.25e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—atherosclerosis	5.34e-06	6.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LPL—atherosclerosis	5.34e-06	6.16e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CAV1—atherosclerosis	5.29e-06	6.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOA1—atherosclerosis	5.28e-06	6.1e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	5.23e-06	6.03e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—atherosclerosis	5.21e-06	6.01e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—atherosclerosis	5.18e-06	5.98e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CG—atherosclerosis	5.09e-06	5.87e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CD36—atherosclerosis	5.07e-06	5.85e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—atherosclerosis	4.98e-06	5.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—atherosclerosis	4.91e-06	5.67e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—INS—atherosclerosis	4.81e-06	5.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—atherosclerosis	4.8e-06	5.55e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—atherosclerosis	4.74e-06	5.47e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARA—atherosclerosis	4.71e-06	5.44e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	4.64e-06	5.35e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AGT—atherosclerosis	4.57e-06	5.27e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—INS—atherosclerosis	4.56e-06	5.27e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—atherosclerosis	4.47e-06	5.16e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAV1—atherosclerosis	4.43e-06	5.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA1—atherosclerosis	4.42e-06	5.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—atherosclerosis	4.41e-06	5.1e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	4.41e-06	5.09e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—atherosclerosis	4.22e-06	4.87e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	4.19e-06	4.84e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—atherosclerosis	4.19e-06	4.84e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	4.15e-06	4.79e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	4.08e-06	4.71e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	4.07e-06	4.69e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CG—atherosclerosis	4.04e-06	4.66e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—atherosclerosis	4e-06	4.62e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—atherosclerosis	3.9e-06	4.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—atherosclerosis	3.86e-06	4.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—INS—atherosclerosis	3.82e-06	4.41e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	3.76e-06	4.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	3.73e-06	4.3e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—atherosclerosis	3.69e-06	4.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	3.56e-06	4.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—atherosclerosis	3.5e-06	4.04e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	3.46e-06	3.99e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—atherosclerosis	3.35e-06	3.87e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—atherosclerosis	2.87e-06	3.32e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT3—atherosclerosis	2.85e-06	3.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MAPK3—atherosclerosis	2.73e-06	3.15e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—atherosclerosis	2.65e-06	3.06e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	2.6e-06	3.01e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	2.4e-06	2.77e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—atherosclerosis	2.38e-06	2.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—atherosclerosis	1.99e-06	2.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—atherosclerosis	1.94e-06	2.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—atherosclerosis	1.84e-06	2.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—atherosclerosis	1.54e-06	1.78e-05	CbGpPWpGaD
